Literature DB >> 22415924

Organometallic ruthenium and iridium transfer-hydrogenation catalysts using coenzyme NADH as a cofactor.

Soledad Betanzos-Lara1, Zhe Liu, Abraha Habtemariam, Ana M Pizarro, Bushra Qamar, Peter J Sadler.   

Abstract

Artificial enzymes: half-sandwich arene ruthenium(II) and cyclopentadienyl iridium(III) complexes containing N,N-chelated ligands can use NADH as a source of hydride for the reduction of ketones. Moreover, cyclopentadienyl phenanthroline iridium(III) derivatives at micromolar concentrations are robust catalysts for the production of H(2) from NADH in water and can raise the NAD(+)/NADH ratio in cancer cells.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22415924     DOI: 10.1002/anie.201108175

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  20 in total

1.  Synthetic cascades are enabled by combining biocatalysts with artificial metalloenzymes.

Authors:  V Köhler; Y M Wilson; M Dürrenberger; D Ghislieri; E Churakova; T Quinto; L Knörr; D Häussinger; F Hollmann; N J Turner; T R Ward
Journal:  Nat Chem       Date:  2012-11-25       Impact factor: 24.427

Review 2.  Using non-enzymatic chemistry to influence microbial metabolism.

Authors:  Stephen Wallace; Erica E Schultz; Emily P Balskus
Journal:  Curr Opin Chem Biol       Date:  2015-01-08       Impact factor: 8.822

3.  Antimicrobial metallopeptides with broad nuclease and ribonuclease activity.

Authors:  Jeff C Joyner; W F Hodnick; Ada S Cowan; Deepika Tamuly; Rachel Boyd; J A Cowan
Journal:  Chem Commun (Camb)       Date:  2013-02-05       Impact factor: 6.222

4.  Synthesis, Characterisation and In Vitro Anticancer Activity of Catalytically Active Indole-Based Half-Sandwich Complexes.

Authors:  Joan J Soldevila-Barreda; Kehinde B Fawibe; Maria Azmanova; Laia Rafols; Anaïs Pitto-Barry; Uche B Eke; Nicolas P E Barry
Journal:  Molecules       Date:  2020-10-03       Impact factor: 4.411

5.  Novel iridium(III) iminopyridine complexes: synthetic, catalytic, and in vitro anticancer activity studies.

Authors:  Deliang Kong; Meng Tian; Lihua Guo; Xicheng Liu; Shumiao Zhang; Yameng Song; Xin Meng; Shu Wu; Lingzi Zhang; Zhe Liu
Journal:  J Biol Inorg Chem       Date:  2018-06-11       Impact factor: 3.358

6.  Synthesis, Structure, Stability, and Inhibition of Tubulin Polymerization by RuII-p-Cymene Complexes of Trimethoxyaniline-Based Schiff Bases.

Authors:  Sourav Acharya; Moumita Maji; Kallol Purkait; Arnab Gupta; Arindam Mukherjee
Journal:  Inorg Chem       Date:  2019-06-26       Impact factor: 5.165

7.  Ligand-Controlled Reactivity and Cytotoxicity of Cyclometalated Rhodium(III) Complexes.

Authors:  Wen-Ying Zhang; Hannah E Bridgewater; Samya Banerjee; Joan J Soldevila-Barreda; Guy J Clarkson; Huayun Shi; Cinzia Imberti; Peter J Sadler
Journal:  Eur J Inorg Chem       Date:  2019-11-20       Impact factor: 2.524

Review 8.  Metallodrugs are unique: opportunities and challenges of discovery and development.

Authors:  Elizabeth J Anthony; Elizabeth M Bolitho; Hannah E Bridgewater; Oliver W L Carter; Jane M Donnelly; Cinzia Imberti; Edward C Lant; Frederik Lermyte; Russell J Needham; Marta Palau; Peter J Sadler; Huayun Shi; Fang-Xin Wang; Wen-Ying Zhang; Zijin Zhang
Journal:  Chem Sci       Date:  2020-11-12       Impact factor: 9.825

9.  Osmium(ii) tethered half-sandwich complexes: pH-dependent aqueous speciation and transfer hydrogenation in cells.

Authors:  Sonia Infante-Tadeo; Vanessa Rodríguez-Fanjul; Abraha Habtemariam; Ana M Pizarro
Journal:  Chem Sci       Date:  2021-06-10       Impact factor: 9.825

10.  Organometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis.

Authors:  Jessica M Hearn; Isolda Romero-Canelón; Bushra Qamar; Zhe Liu; Ian Hands-Portman; Peter J Sadler
Journal:  ACS Chem Biol       Date:  2013-04-25       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.